MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 09-10-2025
Anixa Biosciences DSO Ratio 2011-2025 | ANIX
Annual DSO Ratio Anixa Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 385 | 275 | - | - | - | 97.1 | - | - | - | - | 39.8 | 164 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 385 | 39.8 | 192 |
Quarterly DSO Ratio Anixa Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 55.6 | 4.18 | - | - | - | - | - | - | - | - | - | - | - | - | 24.3 | 24.3 | 12.1 | - | 25.2 | 38.6 | - | - | 27.8 | 27.8 | - | - | - | - | - | 0.22 | - | - | - | - | 15.9 | 30.7 | 16.5 | 3.75 K | - | - | - | 0.71 | 912 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.75 K | 0.22 | 310 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 11.98 | 0.76 % | $ 340 M |  Israel |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
85 | $ 65.83 | -1.69 % | $ 25.4 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.48 | 4.6 % | $ 177 M |  China |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.53 | 0.02 % | $ 18.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 221.78 | -0.22 % | $ 40.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.2 | $ 38.58 | -0.13 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
57 | $ 226.12 | -0.09 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.93 | -0.77 % | $ 814 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
77.8 | $ 11.99 | 1.18 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 6.76 | -1.46 % | $ 1.47 B | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.76 | -3.89 % | $ 1.06 B | USA |
 |
Pacific Biosciences of California
PACB
|
50.4 | $ 2.1 | -1.18 % | $ 533 M | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
Precipio
PRPO
|
28.1 | $ 24.67 | -1.2 % | $ 32 M | USA |
 |
Quidel Corporation
QDEL
|
116 | $ 28.44 | -1.25 % | $ 1.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | $ 45.02 | -0.44 % | $ 10 B |  Niderland |
 |
Guardant Health
GH
|
49.2 | $ 103.45 | 1.35 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
47.8 | $ 16.82 | -0.09 % | $ 4.76 B | USA |
 |
Soleno Therapeutics
SLNO
|
33.5 | $ 50.26 | -3.36 % | $ 2.02 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 134.16 | -0.52 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 196.68 | 1.89 % | $ 10.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
69.9 | $ 571.15 | -0.12 % | $ 218 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.99 | -7.5 % | $ 61.9 M |  Irlanda |
 |
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 30.97 | 0.11 % | $ 1.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 183.34 | 0.43 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.63 | -2.8 % | $ 989 M | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 405.44 | 0.85 % | $ 29.8 B | Schweiz |
 |
Myriad Genetics
MYGN
|
51.3 | $ 6.93 | -3.88 % | $ 628 M | USA |